Thank you, Paul. As Ed mentioned, the 10-Ks we filed this afternoon with the SEC offers a detailed explanation of our annual financials. So I'm just going to provide you with a bit of color on some of the full year as well as quarterly numbers. For the three months ended December 31, 2024, we reported $1.3 million in total revenues as compared to $1.1 million in the prior year's comparable fourth quarter. Revenue increase was primarily due to higher unit sales of our M400 smart glasses. For the full year ended December 31, 2024, Vuzix Corporation reported $5.8 million in total revenues as compared to $12.1 million for the prior year. Product sales decreased by 58% year over year as unit sales of our M400 product declined compared to the previous year when two major distributors placed significant stocking orders in the first half of 2023 representing 54% of our total product sales in 2023. Sales of engineering services for the year ended December 31, 2024, were $1.3 million as compared to $1.4 million in 2023, a decrease of 7%. Please note as disclosed in our 10-Ks, we have $2.1 million of remaining performance obligations over revenues already recognized under a current waveguide development project. For the full year ended December 31, 2024, there was an overall gross loss of $5.6 million as compared to a loss of $2.6 million for 2023. Larger gross loss for 2024 was primarily driven by further inventory obsolescence reserves included in cost of sales and increased unapplied manufacturing overhead costs of $2.1 million due to reduced further builds of the M400 finished goods in the second half of 2024. The larger additional inventory reserve amounts were related to the collected surplus components and obsolescence provision in excess of currently planned existing future product builds in 2025 and early 2026. And all part of our planned transition to expected new smart glasses models now being developed. No finished goods have been included in these inventory reserves. And as the ultimate realizable value of these excess components, that may not be used in future products build is unknown at this time, a 100% obsolescence provision was accrued. Research and development expenses for 2024 fell 22% to $9.6 million as compared to $12.3 million for 2023. The decrease was primarily due to a $1.6 million reduction in salary and benefits, related expenses due to headcount decreases, and a $1 million drop in external development costs. For the fourth quarter of December 31, 2024, research and development expenses were $2.2 million as compared to $3.5 million in the 2023 fourth quarter. The decrease again was driven by headcount reduction. Sales and marketing costs for all of 2024 fell to $8.2 million from $12.7 million in 2023. A reduction of $4.5 million or 36%. The most significant factors for these expense reductions include a $1.6 million decrease in advertising and trade show expenses, and a $1.6 million reduction in salary and benefits expenses driven by headcount decrease. For the fourth quarter of December 31, 2024, sales and marketing expenses were $2 million as compared to $4.8 million in the 2023's fourth quarter. The decrease again was driven by reductions in headcount, and advertising expenses changes in bad debt provisions, and severance accruals booked in Q4 of 2023. General and administrative expenses for 2024 decreased 7% to $17.2 million as compared to $18.6 million for the 2023 period. Decrease was largely due to a $1.4 million decline in noncash stock-based compensation a $1.1 million decline in salary and benefits related expenses due to headcount reductions. Partially offset by a $1 million increase in investor relations. For the fourth quarter ending December 31, 2024, general and administrative expenses were $4.3 million as compared to $4.7 million in the 2023 fourth quarter. Decrease again was driven by headcount reductions. For the fourth quarter ended December 31, 2024, the net loss was $13.7 million or $0.16 per share as compared to a net loss of $19.9 million or $0.32 per share for the fourth quarter of 2023. For the full year ended December 31, 2024, the net loss was $73.5 million or $1.08 per share as compared to a net loss of $50.1 million or $0.79 for the full year of 2023. The increased net loss was mostly attributable to the write-off of our technology license and investment in Atomistic. We was recorded in the second quarter of 2024. Excluding this write-off, the net loss for 2024 was lights. Our cash position as of December 31, 2024, was $18.2 million a decrease of $8.4 million from December 31, 2023. We had a net working capital position of $24.6 million. Net cash flows used in operating activities was $23.7 million for the year ended December 31, 2024, as compared to $26.3 million for the 2023 year, a decrease of $2.6 million. For all of 2024, we raised $18.3 million through financing activities that consist of a $10 million investment by Quanta Computer in September and $8.2 million of net proceeds received from equity sales under our ATM offering in the fourth quarter of 2024. Cash used in investing activities in 2024 was $2.9 million, down significantly from $19.3 million in 2023. Primarily due to reductions in investment amounts and licensing fees paid to Atomistic. And manufacturing equipment and tooling investments for a new waveguide manufacturing facility in 2023. We are presently envisioning spending significantly less on CapEx investment is now adequate for expected demand in the near term. I'm pleased to report that after a year of expense reductions, when we look at our major operating expense groupings, R&D, sales and marketing, and G&A, in our Q4 2024 versus Q4 2023, we reduced our recurring cash operating costs and that's after adding back non-cash compensation, bad debt provisions, and the severance accruals we made at the end of 2023. We saw a $2.7 million reduction per quarter or 36% year over year. We expect to keep these expense savings in place and intend to look further at all our spending in 2025 as we move forward and expand our business. Looking forward in 2025, we are confident that management plans and the expected further funding of the second and third tranches from Quanta which will bring in another $10 million in new cash. Along with potential further equity sales under the ATM program. And of note, we raised $1.3 million to date in 2025, the company has more than adequate resources to move forward with its operating plan well into 2026. And with that, I would like to turn the call back over to the operator for Q&A.